Bio-Techne (TECH) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Bio-Techne Releases Third Quarter Fiscal 2019 Results
April 30, 2019 6:30 AM EDTMINNEAPOLIS, April 30, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2019.
Third Quarter FY2019 Snapshot
Third quarter organic growth of 14% (13% reported) with revenue of $184.9 million. GAAP EPS was $1.15 vs. $0.52 one year ago. Delivered adjusted earnings per share (EPS) of $1.21, consistent with the prior year despite foreign currency exchange headwinds negatively impacting results by $0.10 or 8% in the third quarter. Excellent commercial execution in all major regions, with North America, Europe, and China all achieving double digit organic... More